Navidea Biopharmaceuticals, Inc. (NAVB): Price and Financial Metrics

Navidea Biopharmaceuticals, Inc. (NAVB): $0.04

0.01 (-16.67%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add NAVB to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#386 of 493

in industry

NAVB Price/Volume Stats

Current price $0.04 52-week high $0.28
Prev. close $0.04 52-week low $0.02
Day low $0.04 Volume 15,400
Day high $0.04 Avg. volume 106,159
50-day MA $0.04 Dividend yield N/A
200-day MA $0.06 Market Cap 3.50M

NAVB Stock Price Chart Interactive Chart >


Navidea Biopharmaceuticals, Inc. (NAVB) Company Bio


Navidea Biopharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of precision radiopharmaceutical diagnostics for diseases such as cancer.


NAVB Latest News Stream


Event/Time News Detail
Loading, please wait...

NAVB Latest Social Stream


Loading social stream, please wait...

View Full NAVB Social Stream

Latest NAVB News From Around the Web

Below are the latest news stories about NAVIDEA BIOPHARMACEUTICALS INC that investors may wish to consider to help them evaluate NAVB as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Pre-market stock movers are a hot topic on Tuesday as investors seek out the latest news on the biggest gainers and losers this morning!

William White on InvestorPlace | September 19, 2023

Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing Panel

DUBLIN, Ohio, August 10, 2023--Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing Panel

Yahoo | August 10, 2023

Why Is Navidea Biopharmaceutical (NAVB) Stock Down 13% Today?

Navidea Biopharmaceutical (NAVB) stock is falling on Monday after the biopharmaceutical company got a major delisting warning.

William White on InvestorPlace | July 31, 2023

Why Is SOFI Stock Up 19% Today?

SoFi Technologies (SOFI) stock is on the rise Monday after the financial services company released results for the second quarter of 2023.

William White on InvestorPlace | July 31, 2023

Why Is Sonnet BioTherapeutics (SONN) Stock Down 5% Today?

Sonnet BioTherapeutics (SONN) stock is taking a beating on Monday after the company announced details for a public stock offering.

William White on InvestorPlace | July 31, 2023

Read More 'NAVB' Stories Here

NAVB Price Returns

1-mo -19.84%
3-mo -23.81%
6-mo -20.00%
1-year -84.62%
3-year -97.42%
5-year -98.89%
YTD -27.54%
2023 -73.71%
2022 -79.00%
2021 -53.49%
2020 70.63%
2019 -37.00%

Continue Researching NAVB

Here are a few links from around the web to help you further your research on Navidea Biopharmaceuticals Inc's stock as an investment opportunity:

Navidea Biopharmaceuticals Inc (NAVB) Stock Price | Nasdaq
Navidea Biopharmaceuticals Inc (NAVB) Stock Quote, History and News - Yahoo Finance
Navidea Biopharmaceuticals Inc (NAVB) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!